Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Characterisation of prostate cancer lesions in heterozygous Men1 mutant mice

  • Christelle Seigne1,
  • Sandra Fontanière1, 2,
  • Christine Carreira1, 2,
  • Jieli Lu1, 7,
  • Wei-Ming Tong2, 3,
  • Bernard Fontanière4,
  • Zhao-Qi Wang2, 5,
  • Chang Xian Zhang1, 7Email author and
  • Lucien Frappart6
BMC Cancer201010:395

DOI: 10.1186/1471-2407-10-395

Received: 11 December 2009

Accepted: 27 July 2010

Published: 27 July 2010

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
11 Dec 2009 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
19 Feb 2010 Reviewed Reviewer Report - Cornelis Lips
15 Mar 2010 Reviewed Reviewer Report - Philippe Chanson
4 Jun 2010 Author responded Author comments - Chang Xian Zhang
Resubmission - Version 3
4 Jun 2010 Submitted Manuscript version 3
18 Jun 2010 Reviewed Reviewer Report - Cornelis Lips
17 Jul 2010 Author responded Author comments - Chang Xian Zhang
Resubmission - Version 4
17 Jul 2010 Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
24 Jul 2010 Author responded Author comments - Chang Xian Zhang
Resubmission - Version 6
24 Jul 2010 Submitted Manuscript version 6
Publishing
27 Jul 2010 Editorially accepted
27 Jul 2010 Article published 10.1186/1471-2407-10-395

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
CNRS UMR5201, Laboratoire de Génétique Moléculaire, Signalisation et Cancer, Centre Léon Bérard
(2)
International Agency for Research on Cancer
(3)
Institute of Basic Medical Sciences, Academy of Medical Sciences, Beijing Union Medical College
(4)
Département de Pathologie, Centre Léon Bérard
(5)
Leibniz Institute for Age Research - Fritz Lipmann Institute e.V.
(6)
Département de Pathologie, INSERM U590, Centre Léon Bérard, Hôpital Edouard Herriot
(7)
The E-Institute of Shanghai, Sino-French Life Science and Genomic Research Center, Jiaotong University

Advertisement